• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病中氧化型低密度脂蛋白与冠状动脉计算机断层扫描血管造影高危斑块的关联:一项配对病例对照研究

Association of Oxidized Low-Density Lipoprotein in Nonalcoholic Fatty Liver Disease with High-Risk Plaque on Coronary Computed Tomography Angiography: A Matched Case-Control Study.

作者信息

Nishihara Takahiro, Miyoshi Toru, Ichikawa Keishi, Osawa Kazuhiro, Nakashima Mitsutaka, Miki Takashi, Ito Hiroshi

机构信息

Department of Cardiovascular Medicine, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.

Department of General Internal Medicine 3, Kawasaki Medical School General Medicine Centre, Okayama 700-0821, Japan.

出版信息

J Clin Med. 2022 May 17;11(10):2838. doi: 10.3390/jcm11102838.

DOI:10.3390/jcm11102838
PMID:35628964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9144234/
Abstract

Nonalcoholic fatty liver disease (NAFLD) is a risk factor for the development of atherosclerotic cardiovascular diseases (CVDs), and oxidative stress has been proposed as a shared pathophysiological condition. This study examined whether oxidized low-density lipoprotein (LDL) is involved in the underlying mechanism that links coronary atherosclerosis and NAFLD. This study included 631 patients who underwent coronary computed tomography angiography (CTA) for suspected coronary artery disease. NAFLD was defined on CT images as a liver-to-spleen attenuation ratio of <1.0. Serum-malondialdehyde-modified LDL (MDA-LDL) and coronary CTA findings were analyzed in a propensity-score-matched cohort of patients with NAFLD (n = 150) and those without NAFLD (n = 150). This study analyzed 300 patients (median age, 65 years; 64% men). Patients with NAFLD had higher MDA-LDL levels and a greater presence of CTA-verified high-risk plaques than those without NAFLD. In the multivariate linear regression analysis, MDA-LDL was independently associated with NAFLD (β = 11.337, p = 0.005) and high-risk plaques (β = 12.487, p = 0.007). Increased MDA-LDL may be a mediator between NAFLD and high-risk coronary plaque on coronary CTA. Increased oxidative stress in NAFLD, as assessed using MDA-LDL, may be involved in the development of CVDs.

摘要

非酒精性脂肪性肝病(NAFLD)是动脉粥样硬化性心血管疾病(CVD)发生的一个危险因素,氧化应激被认为是一种共同的病理生理状态。本研究探讨氧化型低密度脂蛋白(LDL)是否参与了冠状动脉粥样硬化与NAFLD之间潜在的机制联系。本研究纳入了631例因疑似冠心病接受冠状动脉计算机断层扫描血管造影(CTA)的患者。NAFLD在CT图像上被定义为肝脾衰减比<1.0。在倾向评分匹配的NAFLD患者队列(n = 150)和无NAFLD患者队列(n = 150)中分析血清丙二醛修饰的LDL(MDA-LDL)和冠状动脉CTA结果。本研究分析了300例患者(中位年龄65岁;64%为男性)。与无NAFLD的患者相比,NAFLD患者的MDA-LDL水平更高,CTA证实的高危斑块更多。在多变量线性回归分析中,MDA-LDL与NAFLD(β = 11.337,p = 0.005)和高危斑块(β = 12.487,p = 0.007)独立相关。MDA-LDL升高可能是NAFLD与冠状动脉CTA上高危冠状动脉斑块之间的一个介导因素。使用MDA-LDL评估的NAFLD中氧化应激增加可能参与了CVD的发生发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5ad/9144234/610bfe0d03f5/jcm-11-02838-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5ad/9144234/39262fa20be6/jcm-11-02838-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5ad/9144234/610bfe0d03f5/jcm-11-02838-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5ad/9144234/39262fa20be6/jcm-11-02838-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5ad/9144234/610bfe0d03f5/jcm-11-02838-g002.jpg

相似文献

1
Association of Oxidized Low-Density Lipoprotein in Nonalcoholic Fatty Liver Disease with High-Risk Plaque on Coronary Computed Tomography Angiography: A Matched Case-Control Study.非酒精性脂肪性肝病中氧化型低密度脂蛋白与冠状动脉计算机断层扫描血管造影高危斑块的关联:一项配对病例对照研究
J Clin Med. 2022 May 17;11(10):2838. doi: 10.3390/jcm11102838.
2
Increased Circulating Malondialdehyde-Modified Low-Density Lipoprotein Level Is Associated with High-Risk Plaque in Coronary Computed Tomography Angiography in Patients Receiving Statin Therapy.接受他汀类药物治疗的患者中,循环中丙二醛修饰的低密度脂蛋白水平升高与冠状动脉计算机断层扫描血管造影中的高危斑块相关。
J Clin Med. 2021 Apr 2;10(7):1480. doi: 10.3390/jcm10071480.
3
Association between higher pericoronary adipose tissue attenuation measured by coronary computed tomography angiography and nonalcoholic fatty liver disease: A matched case-control study.冠状动脉计算机断层血管造影测量的较高冠状动脉脂肪组织衰减与非酒精性脂肪肝的关系:一项匹配的病例对照研究。
Medicine (Baltimore). 2021 Aug 27;100(34):e27043. doi: 10.1097/MD.0000000000027043.
4
Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: a computed tomography angiography study 2:.非酒精性脂肪性肝病与2型糖尿病患者的严重冠状动脉疾病相关:一项计算机断层扫描血管造影研究2。
J Diabetes. 2015 Mar;7(2):279-86. doi: 10.1111/1753-0407.12172. Epub 2014 Jul 29.
5
High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial.在冠状动脉CT血管造影中,高危冠状动脉斑块与非酒精性脂肪性肝病相关,独立于冠状动脉斑块和狭窄负荷:ROMICAT II试验结果
Radiology. 2015 Mar;274(3):693-701. doi: 10.1148/radiol.14140933. Epub 2014 Nov 4.
6
Impact of malondialdehyde-modified low-density lipoprotein on coronary plaque vulnerability in patients not receiving lipid-lowering therapy: a whole coronary analysis with multislice-computed tomography.丙二醛修饰的低密度脂蛋白对未接受降脂治疗患者冠状动脉斑块易损性的影响:多层螺旋计算机断层扫描的全冠状动脉分析
Heart Vessels. 2018 Apr;33(4):351-357. doi: 10.1007/s00380-017-1074-4. Epub 2017 Oct 24.
7
Prognostic value of pericoronary adipose tissue attenuation in patients with non-alcoholic fatty liver disease with suspected coronary artery disease.非酒精性脂肪性肝病合并疑似冠状动脉疾病患者冠状动脉周围脂肪组织衰减的预后价值
Heart Vessels. 2022 Dec;37(12):1977-1984. doi: 10.1007/s00380-022-02107-x. Epub 2022 Jun 7.
8
Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study.非酒精性脂肪性肝病与亚临床冠状动脉粥样硬化的相关性:一项观察性队列研究。
J Hepatol. 2018 May;68(5):1018-1024. doi: 10.1016/j.jhep.2017.12.012. Epub 2017 Dec 20.
9
Impact of Intensive LDL Cholesterol Lowering on Coronary Artery Atherosclerosis Progression: A Serial CT Angiography Study.强化 LDL 胆固醇降低对冠状动脉粥样硬化进展的影响:一项连续 CT 血管造影研究。
JACC Cardiovasc Imaging. 2017 Apr;10(4):437-446. doi: 10.1016/j.jcmg.2016.04.013. Epub 2016 Oct 19.
10
Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study.酒精性脂肪肝导致终末期肝病患者在肝移植前的冠状动脉粥样硬化特征:一项冠状动脉 CTA 研究。
Eur Radiol. 2021 Jan;31(1):494-503. doi: 10.1007/s00330-020-07037-8. Epub 2020 Aug 4.

引用本文的文献

1
Diagnostic value of CT liver-to-spleen attenuation ratio in patients with non-alcoholic fatty liver disease and atherosclerotic plaque.CT肝脾衰减比在非酒精性脂肪性肝病和动脉粥样硬化斑块患者中的诊断价值
Pak J Med Sci. 2024 Nov;40(10):2416-2421. doi: 10.12669/pjms.40.10.10578.
2
The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease.非酒精性脂肪性肝病与动脉粥样硬化性心血管疾病之间的相互作用。
Front Cardiovasc Med. 2023 May 2;10:1116861. doi: 10.3389/fcvm.2023.1116861. eCollection 2023.
3
Association between Cardiovascular Disease and Liver Disease, from a Clinically Pragmatic Perspective as a Cardiologist.

本文引用的文献

1
Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease.氧化应激是非酒精性脂肪性肝病发展的关键调节因子。
Antioxidants (Basel). 2021 Dec 30;11(1):91. doi: 10.3390/antiox11010091.
2
Role of coronary computed tomography angiography (CTA) post the ISCHEMIA trial: Precision prevention based on coronary CTA-derived coronary atherosclerosis.ISCHEMIA 试验后的冠状动脉计算机断层扫描血管造影(CTA)的作用:基于冠状动脉 CTA 衍生的冠状动脉粥样硬化的精准预防。
J Cardiol. 2022 May;79(5):572-580. doi: 10.1016/j.jjcc.2021.12.006. Epub 2021 Dec 30.
3
Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease.
从心内科医生的临床实用角度看心血管疾病与肝脏疾病的关联。
Nutrients. 2023 Feb 1;15(3):748. doi: 10.3390/nu15030748.
肝纤维化与经肝活检证实的非酒精性脂肪性肝病患者的颈动脉粥样硬化相关。
Sci Rep. 2021 Aug 5;11(1):15938. doi: 10.1038/s41598-021-95581-8.
4
Incremental prognostic value of non-alcoholic fatty liver disease over coronary computed tomography angiography findings in patients with suspected coronary artery disease.非酒精性脂肪肝疾病相对于疑似冠心病患者冠状动脉计算机断层血管造影结果的预后增值。
Eur J Prev Cardiol. 2022 Feb 9;28(18):2059-2066. doi: 10.1093/eurjpc/zwab120.
5
Increased Circulating Malondialdehyde-Modified Low-Density Lipoprotein Level Is Associated with High-Risk Plaque in Coronary Computed Tomography Angiography in Patients Receiving Statin Therapy.接受他汀类药物治疗的患者中,循环中丙二醛修饰的低密度脂蛋白水平升高与冠状动脉计算机断层扫描血管造影中的高危斑块相关。
J Clin Med. 2021 Apr 2;10(7):1480. doi: 10.3390/jcm10071480.
6
Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study.非酒精性脂肪性肝病对疑似冠心病的糖尿病患者心血管事件预测的预后价值:一项前瞻性队列研究。
Cardiovasc Diabetol. 2021 Jan 7;20(1):8. doi: 10.1186/s12933-020-01192-4.
7
Society of Cardiovascular Computed Tomography / North American Society of Cardiovascular Imaging - Expert Consensus Document on Coronary CT Imaging of Atherosclerotic Plaque.心血管计算机断层摄影学会/北美心血管成像学会——动脉粥样硬化斑块冠状动脉 CT 成像专家共识文件。
J Cardiovasc Comput Tomogr. 2021 Mar-Apr;15(2):93-109. doi: 10.1016/j.jcct.2020.11.002. Epub 2020 Nov 9.
8
Mechanistic Insights into the Oxidized Low-Density Lipoprotein-Induced Atherosclerosis.氧化型低密度脂蛋白诱导动脉粥样硬化的机制研究。
Oxid Med Cell Longev. 2020 Sep 15;2020:5245308. doi: 10.1155/2020/5245308. eCollection 2020.
9
Higher oxidized high-density lipoprotein to apolipoprotein A-I ratio is associated with high-risk coronary plaque characteristics determined by CT angiography.高密度脂蛋白氧化程度与载脂蛋白 A-I 的比值与 CT 血管造影确定的高危冠状动脉斑块特征有关。
Int J Cardiol. 2021 Feb 1;324:193-198. doi: 10.1016/j.ijcard.2020.09.060. Epub 2020 Sep 25.
10
Prognostic Value of Coronary Computed Tomographic Angiography in Patients With Nonalcoholic Fatty Liver Disease.冠状动脉计算机断层血管造影术在非酒精性脂肪性肝病患者中的预后价值
JACC Cardiovasc Imaging. 2020 Jul;13(7):1628-1630. doi: 10.1016/j.jcmg.2020.01.022. Epub 2020 Mar 18.